Equity (Details) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
7 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
Dec. 12, 2025 |
Jul. 31, 2025 |
Jul. 14, 2025 |
Apr. 30, 2025 |
Mar. 31, 2025 |
Nov. 18, 2024 |
Oct. 28, 2024 |
Jun. 05, 2024 |
Mar. 07, 2024 |
May 23, 2023 |
Mar. 31, 2024 |
Jun. 30, 2023 |
Sep. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2024 |
Dec. 31, 2025 |
Sep. 30, 2025 |
Sep. 30, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Jun. 05, 2025 |
Jun. 04, 2025 |
Feb. 26, 2025 |
Jan. 09, 2025 |
Jan. 06, 2025 |
Dec. 15, 2024 |
Dec. 13, 2024 |
Oct. 09, 2023 |
Jul. 06, 2023 |
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
100,000,000
|
100,000,000
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
10,000,000
|
10,000,000
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of common stock issued and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
$ 11.25
|
|
|
|
|
|
|
|
|
|
| Equity method investment (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,636,544
|
|
|
|
|
|
|
|
|
|
| Deemed contribution (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 162,473
|
|
|
|
|
|
|
|
|
|
|
| Redemption, net of payables due to lab services (in Dollars) |
|
|
|
|
$ 632,916
|
|
|
|
|
|
|
|
|
$ 632,916
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total redemption (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13,377,916
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds (in Dollars) |
|
|
$ 450,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering expenses (in Dollars) |
|
|
$ 25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock |
|
|
|
|
|
|
|
|
|
5,000
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,857,476
|
|
|
4,857,476
|
4,854,009
|
|
|
|
|
|
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,857,852
|
|
|
|
|
|
|
|
|
|
| Purchase common stock |
|
|
121,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
832,576
|
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
72,000
|
|
|
|
|
|
|
|
2,917
|
|
| Stock price per share (in Dollars per share) |
|
|
$ 2.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk-free rate |
|
|
4.01%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.29%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
91.10%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
105.10%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expected life term |
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dividend yield rate |
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants (in Dollars) |
|
|
$ 354,297
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants (in Dollars) |
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
475,500
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,829,871
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued liabilities (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
$ 42,385
|
|
|
|
42,385
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
$ 7.5
|
|
|
|
|
|
|
|
|
|
|
|
$ 9.75
|
|
|
|
|
|
|
|
$ 27
|
|
| Aggregate fair value of the options granted (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
6,115
|
|
|
|
6,115
|
|
|
|
|
|
|
|
|
|
|
|
|
| Professional fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,254,207
|
$ 1,590,268
|
|
|
|
|
|
|
|
|
|
| Fair values of warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(538,213)
|
$ (374,365)
|
|
|
|
|
|
|
|
|
|
| Convertible debt issuance costs (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 54,186
|
|
|
|
|
|
|
|
|
|
|
| Cancelled, warrants |
|
|
|
|
|
|
|
23,288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants, exercised |
|
|
|
87,250
|
|
6,278
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds (in Dollars) |
|
|
18,628
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid-in capital (in Dollars) |
|
|
$ 6,372
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| First Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
66,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
$ 9.75
|
|
|
$ 30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant to purchase |
|
|
|
|
|
|
|
66,667
|
|
|
8,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Second Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
|
621,353
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
$ 7.5
|
|
|
$ 19.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant to purchase |
|
|
|
|
|
|
|
80,000
|
|
|
8,077
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants Issued in March 2024 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk-free rate |
|
|
|
|
|
|
|
|
4.07%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expected life term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dividend yield rate |
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
$ 30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair values of warrants (in Dollars) |
|
|
|
|
|
|
|
|
$ 9,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock price (in Dollars per share) |
|
|
|
|
|
|
|
|
$ 6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
|
85.24%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants Issued in June 2024 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
5,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk-free rate |
|
|
|
|
|
|
|
4.31%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
85.72%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expected life term |
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dividend yield rate |
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
$ 7.5
|
|
|
$ 9.75
|
|
|
|
|
|
$ 7.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair values of warrants (in Dollars) |
|
|
|
|
$ 80,000
|
|
|
$ 72,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock price (in Dollars per share) |
|
|
|
|
|
|
|
$ 10.39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible debt issuance costs (in Dollars) |
|
|
|
|
|
|
|
$ 39,221
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Roth Capital Partners, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock |
|
|
|
|
|
|
|
|
|
|
|
281,843
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate offering price amount (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 3,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Average price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
$ 10.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 2,544,311
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering costs (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 313,541
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Avalon Lab [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity interest, percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40.00%
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of common stock issued and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(50.00%)
|
|
|
|
|
|
|
|
|
|
|
| Consideration issuable shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock |
|
|
|
|
|
|
206,033
|
|
|
|
|
|
|
|
|
|
|
|
|
145,153
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
429,181
|
|
42,381
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair market values (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,880,786
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.53
|
|
|
|
|
|
|
|
| Warrants, exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
429,181
|
42,381
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | First Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 67.5
|
| Pre-funded warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
354,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued (in Dollars) |
|
|
$ 475,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
354,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock Options [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
470,350
|
|
$ 60,000
|
|
(51,159)
|
$ 14,829
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate intrinsic value of both stock options outstanding a (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
| Compensation and related benefits (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,878
|
$ 31,281
|
|
|
|
|
|
|
|
|
|
|
|
| Professional fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,238
|
|
|
|
|
|
|
|
|
|
|
|
|
| RPM [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of own excess |
100.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Debt Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
| July 2025 Convertible Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair market values (in Dollars) |
|
$ 26,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 2024 Convertible Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock |
|
|
|
|
|
|
|
26,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
146,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.5
|
|
|
|
|
|
|
|
|
| Unpaid interest (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 320,282
|
$ 325,486
|
|
|
|
|
|
|
|
|
|
| June 2024 Convertible Note [Member] | Conversion Share [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Converted principal amount (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,010,827
|
|
|
|
|
|
|
|
|
|
|
| Unpaid interest (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 233,795
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,244,622
|
|
|
|
|
|
|
|
|
|
|
| Share price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
$ 1
|
|
|
|
|
|
|
|
|
|
|
| Convertible Debt [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,800
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 320,546
|
|
|
|
|
|
|
|
|
|
| Related Party [Member] | Finder’s fee [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
$ 9.75
|
$ 30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant to purchase |
|
|
|
|
|
|
|
5,333
|
700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mast Hill [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,000
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9.75
|
|
|
$ 9.75
|
|
|
|
|
|
|
|
|
|
|
| Fair value warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,333
|
|
|
5,333
|
|
|
|
|
|
|
|
|
|
|
| Fair values of warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,854
|
$ 3,714
|
|
|
|
|
|
|
|
|
|
| Mast Hill [Member] | Second Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.5
|
|
|
$ 7.5
|
|
|
|
|
|
|
|
|
|
|
| Fair value warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
80,000
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
| Fair values of warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 32,175
|
|
|
|
|
|
|
|
|
|
|
| Mast Hill [Member] | Warrants Issued in March 2024 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
8,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
$ 30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible note payable (in Dollars) |
|
|
|
|
|
|
|
|
$ 20,374
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mast Hill [Member] | Warrants Issued in June 2024 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
66,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
$ 9.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible note payable (in Dollars) |
|
|
|
|
|
|
|
$ 418,194
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mast Hill [Member] | June 2024 Convertible Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72,000
|
|
|
72,000
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
| Converted principal amount (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,010,827
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Third Party [Member] | Warrants Issued in March 2024 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
$ 30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible note payable (in Dollars) |
|
|
|
|
|
|
|
|
$ 1,679
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Third Party [Member] | Warrants Issued in June 2024 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
$ 9.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants Exercised [Member] | Stock Options [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate intrinsic value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
80.00%
|
|
|
|
|
|
|
|
|
|
|
| Risk-free rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.47%
|
|
|
|
|
|
|
|
|
|
|
|
| Volatility rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
83.10%
|
|
|
|
|
|
|
|
|
|
|
|
| Expected life term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Risk-free rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.79%
|
|
|
|
|
|
|
|
|
|
|
|
| Expected life term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
| Series A Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,000,000
|
|
|
|
$ 9,000,000
|
|
|
|
|
|
| Percentage of common stock issued and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 150
|
|
|
$ 150
|
|
|
|
|
|
|
|
|
|
|
| Conversion percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
0
|
9,000
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
0
|
9,000
|
|
|
|
|
|
|
|
|
|
| Issued shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,000
|
|
|
|
|
|
| Series A Convertible Preferred Stock [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
| Series A Convertible Preferred Stock [Member] | Convertible Debt Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
| Series A Convertible Preferred Stock [Member] | Mr. Lu [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issued shares |
9,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series A Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
| Series D Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
|
|
| Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,837,527
|
|
|
$ 8,837,527
|
|
|
|
|
|
$ 1,000
|
|
|
|
|
| Percentage of common stock issued and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.41
|
|
|
$ 2.41
|
$ 2.41
|
|
$ 2.41
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
5,000
|
0
|
|
|
|
5,000
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
5,000
|
0
|
|
|
|
|
|
|
|
|
|
| Issued shares |
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
|
|
|
| Equity method investment (in Dollars) |
$ 9,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deemed contribution (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 162,473
|
|
$ 162,473
|
|
|
|
|
|
|
|
|
|
|
| Series D Preferred Stock [Member] | Avalon Lab [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity interest, percentage |
|
|
|
|
40.00%
|
|
|
|
|
|
|
|
|
40.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series D Preferred Stock [Member] | Conversion Share [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
| Percentage of own excess |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.99%
|
|
|
4.99%
|
|
|
|
|
|
|
|
|
|
|
| Series D Preferred Stock [Member] | Conversion Share [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.41
|
|
|
$ 2.41
|
|
|
|
|
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 56.7
|
|
|
$ 56.7
|
|
|
|
|
|
|
|
|
|
|
| Equity method investment (in Dollars) |
|
|
|
|
$ 11,029,221
|
|
|
|
|
|
|
|
|
$ 11,029,221
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,000,000
|
|
|
|
|
|
|
|
|
|
| Percentage of common stock issued and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 56.7
|
|
|
$ 56.7
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
0
|
11,000
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
0
|
11,000
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 56.7
|
|
|
|
|
|
|
|
|
|
|
| Equity method investment (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,000,000
|
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
|
|
|
|
2,348,695
|
|
|
|
|
|
|
|
|
2,348,695
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,000)
|
|
|
|
|
|
|
|
|
|
|
| Series B Convertible Preferred Stock [Member] | Lab Services MSO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity method investment (in Dollars) |
|
|
|
|
11,000,000
|
|
|
|
|
|
|
|
|
11,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment of closing the redemption (in Dollars) |
|
|
|
|
$ 1,745,000
|
|
|
|
|
|
|
|
|
$ 1,745,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series B Holder [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of common stock issued and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
| Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
| Preferred stock, stated value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,790,000
|
|
|
$ 3,790,000
|
$ 3,500,000
|
|
|
|
|
|
|
$ 1,000
|
|
|
| Percentage of common stock issued and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.41
|
|
|
$ 2.41
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,800
|
|
|
3,800
|
3,500
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,800
|
|
|
3,800
|
3,500
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] | Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,800
|
|
|
3,800
|
3,500
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,800
|
|
|
3,800
|
3,500
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] | Conversion Share [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
| Percentage of own excess |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19.99%
|
|
|
19.99%
|
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] | Minimum [Member] | Conversion Share [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of own excess |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19.99%
|
|
|
19.99%
|
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] | Maximum [Member] | Conversion Share [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of own excess |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.99%
|
|
|
4.99%
|
|
|
|
|
|
|
|
|
|
|
| Series E Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
19,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
$ 14,916,753
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14,916,753
|
|
|
$ 14,916,753
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.5
|
|
|
$ 1.5
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
19,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,500
|
|
|
19,500
|
0
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,500
|
|
|
19,500
|
0
|
|
|
|
|
|
|
|
|
|
| Series E Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value (in Dollars per share) |
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, stated value (in Dollars) |
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
$ 1.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares issued |
19,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
$ 1.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of share value |
100.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series E Convertible Preferred Stock [Member] | Affiliates [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of own excess |
4.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price per share (in Dollars per share) |
|
$ 2.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.41
|
|
|
|
|
|
|
|
|
|
| Sale of stock |
|
300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,500
|
|
|
|
|
|
|
|
|
|
| Preferred stock and received proceeds (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,500,000
|
|
|
|
|
|
|
|
|
|
| Gross proceeds (in Dollars) |
|
$ 290,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering expenses (in Dollars) |
|
$ 10,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Pre-funded warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds (in Dollars) |
|
|
$ 121,203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
| Warrant [Member] | Warrants Issued in March 2024 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
$ 30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value warrants |
|
|
|
|
|
|
|
|
9,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|